Skip to main content
Top
Published in: Current HIV/AIDS Reports 6/2020

01-12-2020 | Human Immunodeficiency Virus | Implementation Science (E Geng, Section Editor)

Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation

Author: Sarah K. Calabrese

Published in: Current HIV/AIDS Reports | Issue 6/2020

Login to get access

Abstract

Purpose of Review

HIV pre-exposure prophylaxis (PrEP) is a safe and effective preventive intervention that could play a central role in ending the HIV epidemic. However, low uptake in general, and among certain social groups in particular, underscores the need to identify and address barriers to PrEP use. PrEP stigma has emerged as a key factor interfering with PrEP interest, uptake, and continuation. The purpose of this article is to describe and contextualize PrEP stigma and to offer recommendations on how to address it in future PrEP implementation initiatives.

Recent Findings

PrEP users are commonly stereotyped as sexually irresponsible, promiscuous, and immoral. These stereotypes and associated prejudice manifest at multiple levels and discourage PrEP interest and uptake, disrupt PrEP adherence, and motivate PrEP discontinuation. Intersecting forms of stigma may influence the nature, magnitude, and impact of PrEP stigma across social groups and otherwise hinder PrEP use. Current PrEP implementation strategies that narrowly focus on risk and target stigmatized groups with disproportionately high HIV incidence have yielded limited success and are counterproductive to the extent that they perpetuate stigma. Implementation strategies involving more inclusive messaging and further integration of PrEP within healthcare may help to reduce PrEP stigma and mitigate its impact, ultimately increasing PrEP use.

Summary

PrEP stigma is a barrier to PrEP interest, uptake, and continuation that manifests at multiple levels. Understanding and addressing PrEP stigma requires consideration of its origins and intersections. Targeted, risk-focused implementation strategies perpetuate stigma and undermine use.
Literature
2.
go back to reference Harris NS, Johnson AS, Huang YA, Kern D, Fulton P, Smith DK, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013-2018. Morb Mortal Wkly Rep. 2019;68(48):1117–23. Harris NS, Johnson AS, Huang YA, Kern D, Fulton P, Smith DK, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013-2018. Morb Mortal Wkly Rep. 2019;68(48):1117–23.
3.
go back to reference Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review. HIV AIDS (Auckl). 2015;7:241–9. Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review. HIV AIDS (Auckl). 2015;7:241–9.
4.
go back to reference • Herron PD. Current perspectives on the impact of pre-exposure prophylaxis stigma regarding men who have sex with men in the United States. HIV AIDS (Auckl). 2020;12:187–92 This review discusses the origins of PrEP stigma and future mitigation strategies. • Herron PD. Current perspectives on the impact of pre-exposure prophylaxis stigma regarding men who have sex with men in the United States. HIV AIDS (Auckl). 2020;12:187–92 This review discusses the origins of PrEP stigma and future mitigation strategies.
5.
go back to reference •• Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018;15(2):190–7 This review describes several mechanisms via which PrEP stigma impedes scalability, thoroughly addresses the issue of risk compensation, and offers actionable recommendations for addressing stigma. •• Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018;15(2):190–7 This review describes several mechanisms via which PrEP stigma impedes scalability, thoroughly addresses the issue of risk compensation, and offers actionable recommendations for addressing stigma.
6.
go back to reference •• Golub SA, Myers JE. Next-wave HIV pre-exposure prophylaxis implementation for gay and bisexual men. AIDS Patient Care STDS. 2019;33(6):253–61 This article illuminates how a risk-driven approach undermines PrEP implementation and emphasizes the importance of integrating PrEP with other health services. •• Golub SA, Myers JE. Next-wave HIV pre-exposure prophylaxis implementation for gay and bisexual men. AIDS Patient Care STDS. 2019;33(6):253–61 This article illuminates how a risk-driven approach undermines PrEP implementation and emphasizes the importance of integrating PrEP with other health services.
7.
go back to reference Goffman E. Stigma: notes on the management of a spoiled identity. New York, NY: Simon & Schuster, Inc.; 1963. Goffman E. Stigma: notes on the management of a spoiled identity. New York, NY: Simon & Schuster, Inc.; 1963.
8.
go back to reference Major B, Dovidio JF, Link BG, Calabrese SK. Stigma and its implications for health: introduction and overview. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York: Oxford University Press; 2018. p. 1–28. Major B, Dovidio JF, Link BG, Calabrese SK. Stigma and its implications for health: introduction and overview. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York: Oxford University Press; 2018. p. 1–28.
9.
go back to reference Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27(1):363–5. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27(1):363–5.
10.
go back to reference Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–77.PubMedPubMedCentral Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–77.PubMedPubMedCentral
11.
go back to reference Hatzenbuehler ML, Link BG. Introduction to the special issue on structural stigma and health. Soc Sci Med. 2014;103:1–6.PubMed Hatzenbuehler ML, Link BG. Introduction to the special issue on structural stigma and health. Soc Sci Med. 2014;103:1–6.PubMed
13.
go back to reference Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.PubMedPubMedCentral Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.PubMedPubMedCentral
14.
go back to reference Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017;8(9):730.PubMedPubMedCentral Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017;8(9):730.PubMedPubMedCentral
15.
go back to reference Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964–73. Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964–73.
16.
go back to reference • Quinn K, Bowleg L, Dickson-Gomez J. “The fear of being Black plus the fear of being gay”: the effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019;232:86–93. This article provides insights about stigma intersectionality in the context of PrEP. • Quinn K, Bowleg L, Dickson-Gomez J. “The fear of being Black plus the fear of being gay”: the effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019;232:86–93. This article provides insights about stigma intersectionality in the context of PrEP.
17.
go back to reference Spieldenner A. PrEP whores and HIV prevention: the queer communication of HIV pre-exposure prophylaxis (PrEP). J Homosex. 2016;63(12):1685–97.PubMed Spieldenner A. PrEP whores and HIV prevention: the queer communication of HIV pre-exposure prophylaxis (PrEP). J Homosex. 2016;63(12):1685–97.PubMed
19.
go back to reference Golub SA, Lelutiu-Weinberger C, Surace A. Experimental investigation of implicit HIV and preexposure prophylaxis stigma: evidence for ancillary benefits of preexposure prophylaxis use. J Acquir Immune Defic Syndr. 2018;77(3):264–71.PubMed Golub SA, Lelutiu-Weinberger C, Surace A. Experimental investigation of implicit HIV and preexposure prophylaxis stigma: evidence for ancillary benefits of preexposure prophylaxis use. J Acquir Immune Defic Syndr. 2018;77(3):264–71.PubMed
20.
go back to reference Martinez JE, Jonas KJ. Social judgments of sexual behavior and use of HIV pre-exposure prophylaxis. Soc Cogn. 2020;38(1):1–20. Martinez JE, Jonas KJ. Social judgments of sexual behavior and use of HIV pre-exposure prophylaxis. Soc Cogn. 2020;38(1):1–20.
21.
go back to reference Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.PubMedPubMedCentral Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.PubMedPubMedCentral
22.
go back to reference Bourne A, Cassolato M, Thuan Wei CK, Wang B, Pang J, Lim SH, et al. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study. J Int AIDS Soc. 2017;20(1):21899. Bourne A, Cassolato M, Thuan Wei CK, Wang B, Pang J, Lim SH, et al. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study. J Int AIDS Soc. 2017;20(1):21899.
23.
go back to reference Sun CJ, Anderson KM, Toevs K, Morrison D, Wells C, Nicolaidis C. “Little tablets of gold”: an examination of the psychological and social dimensions of PrEP among LGBTQ communities. AIDS Educ Prev. 2019;31(1):51–62. Sun CJ, Anderson KM, Toevs K, Morrison D, Wells C, Nicolaidis C. “Little tablets of gold”: an examination of the psychological and social dimensions of PrEP among LGBTQ communities. AIDS Educ Prev. 2019;31(1):51–62.
24.
go back to reference Pawson M, Grov C. ‘It’s just an excuse to slut around’: gay and bisexual mens' constructions of HIV pre-exposure prophylaxis (PrEP) as a social problem. Sociol Health Illn. 2018;40(8):1391–403.PubMed Pawson M, Grov C. ‘It’s just an excuse to slut around’: gay and bisexual mens' constructions of HIV pre-exposure prophylaxis (PrEP) as a social problem. Sociol Health Illn. 2018;40(8):1391–403.PubMed
25.
go back to reference Franks J, Hirsch-Moverman Y, Loquere AS Jr, Amico KR, Grant RM, Dye BJ, et al. Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139–49. Franks J, Hirsch-Moverman Y, Loquere AS Jr, Amico KR, Grant RM, Dye BJ, et al. Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139–49.
26.
go back to reference Brooks RA, Nieto O, Landrian A, Donohoe TJ. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men. AIDS Care. 2019;31(4):427–35. Brooks RA, Nieto O, Landrian A, Donohoe TJ. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men. AIDS Care. 2019;31(4):427–35.
27.
28.
go back to reference Patel VV, Santoro AF, Chaudhry J, Krasz AK, Golub SA, Mayer KH, et al. Primary care providers' role in HIV prevention with pre-exposure prophylaxis (PrEP): perspectives from young men of color who have sex with men. 11th International Conference on HIV Treatment and Prevention Adherence, Abstract 184. May 2016; Fort Lauderdale, FL. Patel VV, Santoro AF, Chaudhry J, Krasz AK, Golub SA, Mayer KH, et al. Primary care providers' role in HIV prevention with pre-exposure prophylaxis (PrEP): perspectives from young men of color who have sex with men. 11th International Conference on HIV Treatment and Prevention Adherence, Abstract 184. May 2016; Fort Lauderdale, FL.
29.
go back to reference Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Mens Health. 2018;12(6):1843–54.PubMedPubMedCentral Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Mens Health. 2018;12(6):1843–54.PubMedPubMedCentral
30.
go back to reference Smith DK, Herbst JH, Rose CE. Estimating HIV protective effects of method adherence with combinations of preexposure prophylaxis and condom use among African American men who have sex with men. Sex Transm Dis. 2015;42(2):88–92.PubMed Smith DK, Herbst JH, Rose CE. Estimating HIV protective effects of method adherence with combinations of preexposure prophylaxis and condom use among African American men who have sex with men. Sex Transm Dis. 2015;42(2):88–92.PubMed
31.
go back to reference Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.
32.
go back to reference Weeks J. The sexual citizen. Theory Cult Soc. 1998;15(3–4):35–52. Weeks J. The sexual citizen. Theory Cult Soc. 1998;15(3–4):35–52.
33.
go back to reference Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am J Public Health. 2015;105(10):1960–4.PubMedPubMedCentral Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am J Public Health. 2015;105(10):1960–4.PubMedPubMedCentral
34.
go back to reference Elopre L, McDavid C, Brown A, Shurbaji S, Mugavero MJ, Turan JM. Perceptions of HIV pre-exposure prophylaxis among young, Black men who have sex with men. AIDS Patient Care STDS. 2018;32(12):511–8. Elopre L, McDavid C, Brown A, Shurbaji S, Mugavero MJ, Turan JM. Perceptions of HIV pre-exposure prophylaxis among young, Black men who have sex with men. AIDS Patient Care STDS. 2018;32(12):511–8.
35.
go back to reference Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46–53. Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46–53.
36.
go back to reference Puppo C, Spire B, Morel S, Genin M, Beniguel L, Costagliola D, et al. How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study. AIDS Care. 2020;32(sup2):32–9.PubMed Puppo C, Spire B, Morel S, Genin M, Beniguel L, Costagliola D, et al. How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study. AIDS Care. 2020;32(sup2):32–9.PubMed
37.
go back to reference Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, Bologna ES, Beauchamps L, et al. Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi. PLoS One. 2017;12(2):e0172354.PubMedPubMedCentral Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, Bologna ES, Beauchamps L, et al. Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi. PLoS One. 2017;12(2):e0172354.PubMedPubMedCentral
38.
go back to reference Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS One. 2020;15(4):e0228620. Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS One. 2020;15(4):e0228620.
39.
go back to reference Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737–47.PubMedPubMedCentral Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737–47.PubMedPubMedCentral
40.
go back to reference Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. “Support your client at the space that they’re in”: pre-exposure prophylaxis (PrEP) prescribers’ perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196–204. Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. “Support your client at the space that they’re in”: pre-exposure prophylaxis (PrEP) prescribers’ perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196–204.
41.
go back to reference Mack N, Wong C, McKenna K, Lemons A, Odhiambo J, Agot K. Human resource challenges to integrating HIV pre-exposure prophylaxis (PrEP) into the public health system in Kenya: a qualitative study. Afr J Reprod Health. 2015;19(1):54–62.PubMed Mack N, Wong C, McKenna K, Lemons A, Odhiambo J, Agot K. Human resource challenges to integrating HIV pre-exposure prophylaxis (PrEP) into the public health system in Kenya: a qualitative study. Afr J Reprod Health. 2015;19(1):54–62.PubMed
42.
go back to reference Owens C, Hubach RD, Williams D, Lester J, Reece M, Dodge B. Exploring the pre-exposure prophylaxis (PrEP) health care experiences among men who have sex with men (MSM) who live in rural areas of the Midwest. AIDS Educ Prev. 2020;32(1):51–66.PubMed Owens C, Hubach RD, Williams D, Lester J, Reece M, Dodge B. Exploring the pre-exposure prophylaxis (PrEP) health care experiences among men who have sex with men (MSM) who live in rural areas of the Midwest. AIDS Educ Prev. 2020;32(1):51–66.PubMed
43.
go back to reference Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to PrEP: what medical records reveal about access to HIV pre-exposure prophylaxis. J Gen Intern Med. 2020;35(3):832–8.PubMed Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to PrEP: what medical records reveal about access to HIV pre-exposure prophylaxis. J Gen Intern Med. 2020;35(3):832–8.PubMed
44.
go back to reference Hedrick AM, Carpentier FRD. How current and potential pre-exposure prophylaxis (PrEP) users experience, negotiate and manage stigma: disclosures and backstage processes in online discourse. Cult Health Sex [journal on the Internet]. 26 Jun 2020 [cited 15 Sep 2020]. https://doi.org/10.1080/13691058.2020.1752398. Hedrick AM, Carpentier FRD. How current and potential pre-exposure prophylaxis (PrEP) users experience, negotiate and manage stigma: disclosures and backstage processes in online discourse. Cult Health Sex [journal on the Internet]. 26 Jun 2020 [cited 15 Sep 2020]. https://​doi.​org/​10.​1080/​13691058.​2020.​1752398.
45.
go back to reference Calabrese SK, Earnshaw VA, Underhill K, Krakower DS, Magnus M, Hansen NB, et al. Prevention paradox: medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. J Int AIDS Soc. 2018;21(6):e25147.PubMedPubMedCentral Calabrese SK, Earnshaw VA, Underhill K, Krakower DS, Magnus M, Hansen NB, et al. Prevention paradox: medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. J Int AIDS Soc. 2018;21(6):e25147.PubMedPubMedCentral
46.
go back to reference Schwartz J, Grimm J. PrEP on twitter: information, barriers, and stigma. Health Commun. 2017;32(4):509–16.PubMed Schwartz J, Grimm J. PrEP on twitter: information, barriers, and stigma. Health Commun. 2017;32(4):509–16.PubMed
47.
go back to reference Card KG, Hawkins BW, Mortazavi L, Gregory A, Ng KH, Lachowsky NJ. Stigma, the media, and pre-exposure prophylaxis for HIV prevention: observations for enhancing knowledge translation and resisting stigma in the Canadian context. AIDS Behav. 2019;23(7):1877–87. Card KG, Hawkins BW, Mortazavi L, Gregory A, Ng KH, Lachowsky NJ. Stigma, the media, and pre-exposure prophylaxis for HIV prevention: observations for enhancing knowledge translation and resisting stigma in the Canadian context. AIDS Behav. 2019;23(7):1877–87.
48.
go back to reference McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, et al. Propagation of information about preexposure prophylaxis (PrEP) for HIV prevention through Twitter. Health Commun. 2016;31(8):998–1007. McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, et al. Propagation of information about preexposure prophylaxis (PrEP) for HIV prevention through Twitter. Health Commun. 2016;31(8):998–1007.
49.
go back to reference Phillips G 2nd, Raman AB, Felt D, McCuskey DJ, Hayford CS, Pickett J, et al. PrEP4Love: the role of messaging and prevention advocacy in PrEP attitudes, perceptions, and uptake among YMSM and transgender women. J Acquir Immune Defic Syndr. 2020;83(5):450–6.PubMedPubMedCentral Phillips G 2nd, Raman AB, Felt D, McCuskey DJ, Hayford CS, Pickett J, et al. PrEP4Love: the role of messaging and prevention advocacy in PrEP attitudes, perceptions, and uptake among YMSM and transgender women. J Acquir Immune Defic Syndr. 2020;83(5):450–6.PubMedPubMedCentral
51.
go back to reference Quinn KG, Christenson E, Sawkin MT, Hacker E, Walsh JL. The unanticipated benefits of PrEP for young black gay, bisexual, and other men who have sex with men. AIDS Behav. 2020;24(5):1376–88.PubMedPubMedCentral Quinn KG, Christenson E, Sawkin MT, Hacker E, Walsh JL. The unanticipated benefits of PrEP for young black gay, bisexual, and other men who have sex with men. AIDS Behav. 2020;24(5):1376–88.PubMedPubMedCentral
52.
go back to reference Bazzi AR, Leech AA, Biancarelli DL, Sullivan M, Drainoni ML. Experiences using pre-exposure prophylaxis for safer conception among HIV serodiscordant heterosexual couples in the United States. AIDS Patient Care STDS. 2017;31(8):348–55. Bazzi AR, Leech AA, Biancarelli DL, Sullivan M, Drainoni ML. Experiences using pre-exposure prophylaxis for safer conception among HIV serodiscordant heterosexual couples in the United States. AIDS Patient Care STDS. 2017;31(8):348–55.
53.
go back to reference Hynie M, Lydon JE. Women's perceptions of female contraceptive behavior: experimental evidence of the sexual double standard. Psychol Women Q. 1995;19(4):563–81.PubMed Hynie M, Lydon JE. Women's perceptions of female contraceptive behavior: experimental evidence of the sexual double standard. Psychol Women Q. 1995;19(4):563–81.PubMed
54.
go back to reference Scales P. Males and morals: teenage contraceptive behavior amid the double standard. Fam Coord. 1977;26:211–22. Scales P. Males and morals: teenage contraceptive behavior amid the double standard. Fam Coord. 1977;26:211–22.
55.
go back to reference Biello KB, Oldenburg CE, Mitty JA, Closson EF, Mayer KH, Safren SA, et al. The “safe sex” conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex. AIDS Behav. 2017;21(1):300–6. Biello KB, Oldenburg CE, Mitty JA, Closson EF, Mayer KH, Safren SA, et al. The “safe sex” conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex. AIDS Behav. 2017;21(1):300–6.
56.
go back to reference Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018;22(9):3044–56.PubMedPubMedCentral Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018;22(9):3044–56.PubMedPubMedCentral
57.
go back to reference Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, Krakower D, Novak DS, Mimiaga MJ, et al. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS. 2015;29(7):837–45. Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, Krakower D, Novak DS, Mimiaga MJ, et al. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS. 2015;29(7):837–45.
58.
go back to reference Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. Gendered social institutions and preventive healthcare seeking for Black men who have sex with men: the promise of biomedical HIV prevention. Arch Sex Behav. 2018;47(7):2091–100. Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. Gendered social institutions and preventive healthcare seeking for Black men who have sex with men: the promise of biomedical HIV prevention. Arch Sex Behav. 2018;47(7):2091–100.
59.
go back to reference Furukawa NW, Maksut JL, Zlotorzynska M, Sanchez TH, Smith DK, Baral SD. Sexuality disclosure in U.S. gay, bisexual, and other men who have sex with men: impact on healthcare-related stigmas and HIV pre-exposure prophylaxis denial. Am J Prev Med. 2020;59(2):e79–e87. Furukawa NW, Maksut JL, Zlotorzynska M, Sanchez TH, Smith DK, Baral SD. Sexuality disclosure in U.S. gay, bisexual, and other men who have sex with men: impact on healthcare-related stigmas and HIV pre-exposure prophylaxis denial. Am J Prev Med. 2020;59(2):e79–e87.
60.
go back to reference Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. Culturally competent sexual healthcare as a prerequisite for obtaining preexposure prophylaxis: findings from a qualitative study. LGBT Health. 2017;4(4):310–4.PubMedPubMedCentral Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. Culturally competent sexual healthcare as a prerequisite for obtaining preexposure prophylaxis: findings from a qualitative study. LGBT Health. 2017;4(4):310–4.PubMedPubMedCentral
63.
go back to reference Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102–10.PubMedPubMedCentral Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102–10.PubMedPubMedCentral
64.
go back to reference Calabrese SK, Earnshaw VA, Magnus M, Hansen NB, Krakower DS, Underhill K, et al. Sexual stereotypes ascribed to black men who have sex with men: an intersectional analysis. Arch Sex Behav. 2018;47(1):143–56. Calabrese SK, Earnshaw VA, Magnus M, Hansen NB, Krakower DS, Underhill K, et al. Sexual stereotypes ascribed to black men who have sex with men: an intersectional analysis. Arch Sex Behav. 2018;47(1):143–56.
65.•
go back to reference Brown G, Leonard W, Lyons A, Power J, Sander D, McColl W, et al. Stigma, gay men and biomedical prevention: the challenges and opportunities of a rapidly changing HIV prevention landscape. Sex Health. 2017;14(1):111–8 This article reviews the historical context for PrEP stigma as experienced by gay men and anticipates future challenges and opportunities.PubMed Brown G, Leonard W, Lyons A, Power J, Sander D, McColl W, et al. Stigma, gay men and biomedical prevention: the challenges and opportunities of a rapidly changing HIV prevention landscape. Sex Health. 2017;14(1):111–8 This article reviews the historical context for PrEP stigma as experienced by gay men and anticipates future challenges and opportunities.PubMed
67.
go back to reference Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. J Acquir Immune Defic Syndr. 2019;81(4):395–405. Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. J Acquir Immune Defic Syndr. 2019;81(4):395–405.
68.
go back to reference Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, Rodolph M, Baggaley R. Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health. 2018;15(6):489–500.PubMed Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, Rodolph M, Baggaley R. Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health. 2018;15(6):489–500.PubMed
69.
go back to reference Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the Motivational PrEP Cascade. J Acquir Immune Defic Syndr. 2017;4(3):285–92. Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the Motivational PrEP Cascade. J Acquir Immune Defic Syndr. 2017;4(3):285–92.
70.
go back to reference Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.PubMedPubMedCentral Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.PubMedPubMedCentral
71.
go back to reference Shover CL, Javanbakht M, Shoptaw S, Bolan RK, Lee S-J, Parsons JT, et al. HIV preexposure prophylaxis initiation at a large community clinic: differences between eligibility, awareness, and uptake. Am J Public Health. 2018;108(10):1408–17. Shover CL, Javanbakht M, Shoptaw S, Bolan RK, Lee S-J, Parsons JT, et al. HIV preexposure prophylaxis initiation at a large community clinic: differences between eligibility, awareness, and uptake. Am J Public Health. 2018;108(10):1408–17.
72.
go back to reference Tims-Cook Z. A retrospective assessment of antecedent pre-exposure prophylaxis eligibility of HIV-positive women in the south. AIDS Patient Care STDS. 2019;33(9):384–7.PubMed Tims-Cook Z. A retrospective assessment of antecedent pre-exposure prophylaxis eligibility of HIV-positive women in the south. AIDS Patient Care STDS. 2019;33(9):384–7.PubMed
73.
go back to reference Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, NHBS Study Group. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-20 US Cities, 2014. Clin Infect Dis. 2016;63(5):672–7. Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, NHBS Study Group. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-20 US Cities, 2014. Clin Infect Dis. 2016;63(5):672–7.
74.
go back to reference Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, et al. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015;25(6):445–54. Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, et al. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015;25(6):445–54.
75.
go back to reference Blumenthal J, Jain S, Mulvihill E, Sun S, Hanashiro M, Ellorin E, et al. Perceived versus calculated HIV risk: implications for pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr. 2019;80(2):e23–9. Blumenthal J, Jain S, Mulvihill E, Sun S, Hanashiro M, Ellorin E, et al. Perceived versus calculated HIV risk: implications for pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr. 2019;80(2):e23–9.
76.
go back to reference Kesler MA, Kaul R, Myers T, Liu J, Loutfy M, Remis RS, et al. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada. AIDS Care. 2016;28(11):1378–85. Kesler MA, Kaul R, Myers T, Liu J, Loutfy M, Remis RS, et al. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada. AIDS Care. 2016;28(11):1378–85.
77.
go back to reference Xie L, Wu Y, Meng S, Hou J, Fu R, Zheng H, et al. Risk behavior not associated with self-perception of PrEP candidacy: implications for designing PrEP services. AIDS Behav. 2019;23(10):2784–94. Xie L, Wu Y, Meng S, Hou J, Fu R, Zheng H, et al. Risk behavior not associated with self-perception of PrEP candidacy: implications for designing PrEP services. AIDS Behav. 2019;23(10):2784–94.
78.
go back to reference Jay JS, Gostin LO. Ethical challenges of preexposure prophylaxis for HIV. JAMA. 2012;308(9):867–8.PubMed Jay JS, Gostin LO. Ethical challenges of preexposure prophylaxis for HIV. JAMA. 2012;308(9):867–8.PubMed
79.
go back to reference Kessler J, Myers JE, Nucifora KA, Mensah N, Toohey C, Khademi A, et al. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York. AIDS. 2014;28(18):2683–91. Kessler J, Myers JE, Nucifora KA, Mensah N, Toohey C, Khademi A, et al. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York. AIDS. 2014;28(18):2683–91.
80.
go back to reference Philpott S. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis. Am J Prev Med. 2013;44(1 Suppl 2):S137–40.PubMed Philpott S. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis. Am J Prev Med. 2013;44(1 Suppl 2):S137–40.PubMed
81.
go back to reference Amico KR, Bekker LG. Global PrEP roll-out: recommendations for programmatic success. Lancet HIV. 2019;6(2):e137-40. Amico KR, Bekker LG. Global PrEP roll-out: recommendations for programmatic success. Lancet HIV. 2019;6(2):e137-40.
82.
go back to reference Rogers BG, Whiteley L, Haubrick KK, Mena LA, Brown LK. Intervention messaging about pre-exposure prophylaxis use among young, Black sexual minority men. AIDS Patient Care STDS. 2019;33(11):473–81.PubMedPubMedCentral Rogers BG, Whiteley L, Haubrick KK, Mena LA, Brown LK. Intervention messaging about pre-exposure prophylaxis use among young, Black sexual minority men. AIDS Patient Care STDS. 2019;33(11):473–81.PubMedPubMedCentral
83.
go back to reference Calabrese SK, Dovidio JF, Patel VV, Modrakovic D, Boone CA, Galvao RW et al. The stigmatizing effect of “targeting” US Black men who have sex with men in the social marketing of PrEP: a mixed methods study. 23rd International AIDS Conference (AIDS 2020), Abstract PED0973. Jul 2020; Virtual. Calabrese SK, Dovidio JF, Patel VV, Modrakovic D, Boone CA, Galvao RW et al. The stigmatizing effect of “targeting” US Black men who have sex with men in the social marketing of PrEP: a mixed methods study. 23rd International AIDS Conference (AIDS 2020), Abstract PED0973. Jul 2020; Virtual.
84.
go back to reference Nakasone SE, Young I, Estcourt CS, Calliste J, Flowers P, Ridgway J, et al. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK. Sex Transm Infect. 2020;96:349–54. Nakasone SE, Young I, Estcourt CS, Calliste J, Flowers P, Ridgway J, et al. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK. Sex Transm Infect. 2020;96:349–54.
85.
go back to reference Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in Black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.PubMedPubMedCentral Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in Black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.PubMedPubMedCentral
86.
go back to reference Calabrese SK, Underhill K, Earnshaw VA, Hansen NB, Kershaw TS, Magnus M, et al. Framing HIV pre-exposure prophylaxis (PrEP) for the general public: how inclusive messaging may prevent prejudice from diminishing public support. AIDS Behav. 2016;20(7):1499–513. Calabrese SK, Underhill K, Earnshaw VA, Hansen NB, Kershaw TS, Magnus M, et al. Framing HIV pre-exposure prophylaxis (PrEP) for the general public: how inclusive messaging may prevent prejudice from diminishing public support. AIDS Behav. 2016;20(7):1499–513.
87.
go back to reference Herek GM, Capitanio JP. AIDS stigma and sexual prejudice. Am Behav Sci. 1999;42(7):1130–47. Herek GM, Capitanio JP. AIDS stigma and sexual prejudice. Am Behav Sci. 1999;42(7):1130–47.
88.
go back to reference Fields EL, Long A, Bademosi K, Granderson R, Schumacher CM, Chandran A, et al. Identifying community-informed language to promote HIV pre-exposure prophylaxis (PrEP) in Black LGBTQ communities in Baltimore. AIDS Educ Prev. 2020;32(2):152–68. Fields EL, Long A, Bademosi K, Granderson R, Schumacher CM, Chandran A, et al. Identifying community-informed language to promote HIV pre-exposure prophylaxis (PrEP) in Black LGBTQ communities in Baltimore. AIDS Educ Prev. 2020;32(2):152–68.
89.
go back to reference Fischer LS, Mansergh G, Lynch J, Santibanez S. Addressing disease-related stigma during infectious disease outbreaks. Disaster Med Public Health Prep. 2019;13(5–6):989–94.PubMedPubMedCentral Fischer LS, Mansergh G, Lynch J, Santibanez S. Addressing disease-related stigma during infectious disease outbreaks. Disaster Med Public Health Prep. 2019;13(5–6):989–94.PubMedPubMedCentral
90.
go back to reference Corrigan PW, Bink AB, Schmidt A. Reducing physical illness stigma: insights from the mental illness arena. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York: Oxford University Press; 2018. p. 413–27. Corrigan PW, Bink AB, Schmidt A. Reducing physical illness stigma: insights from the mental illness arena. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York: Oxford University Press; 2018. p. 413–27.
91.
go back to reference Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.PubMedPubMedCentral Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.PubMedPubMedCentral
92.
go back to reference Calabrese SK, Krakower DS, Mayer KH. Integrating HIV pre-exposure prophylaxis (PrEP) into routine preventive healthcare to avoid exacerbating disparities. Am J Public Health. 2017;107(12):1883–9.PubMedPubMedCentral Calabrese SK, Krakower DS, Mayer KH. Integrating HIV pre-exposure prophylaxis (PrEP) into routine preventive healthcare to avoid exacerbating disparities. Am J Public Health. 2017;107(12):1883–9.PubMedPubMedCentral
93.
go back to reference O'Connell HR, Criniti SM. The impact of HIV pre-exposure prophylaxis (PrEP) counseling on PrEP knowledge and attitudes among women seeking family planning care. J Womens Health [journal on the Internet]. 3 Jun 2020 [cited 15 Sep 2020]. https://doi.org/10.1089/jwh.2019.8217. O'Connell HR, Criniti SM. The impact of HIV pre-exposure prophylaxis (PrEP) counseling on PrEP knowledge and attitudes among women seeking family planning care. J Womens Health [journal on the Internet]. 3 Jun 2020 [cited 15 Sep 2020]. https://​doi.​org/​10.​1089/​jwh.​2019.​8217.
94.
go back to reference Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, et al. Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings. Curr HIV/AIDS Rep. 2016;13(2):116–24. Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, et al. Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings. Curr HIV/AIDS Rep. 2016;13(2):116–24.
95.
go back to reference Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Bernstein KT, et al. HIV preexposure prophylaxis as a gateway to primary care. Am J Public Health. 2018;108(10):1418–20. Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Bernstein KT, et al. HIV preexposure prophylaxis as a gateway to primary care. Am J Public Health. 2018;108(10):1418–20.
96.
go back to reference Friend DR, Clark JT, Kiser PF, Clark MR. Multipurpose prevention technologies: products in development. Antivir Res. 2013;100(Suppl):S39–47.PubMed Friend DR, Clark JT, Kiser PF, Clark MR. Multipurpose prevention technologies: products in development. Antivir Res. 2013;100(Suppl):S39–47.PubMed
97.
go back to reference Klein H, Washington TA. The pre-exposure prophylaxis (PrEP) stigma scale: preliminary findings from a pilot study. Int Public Health J. 2019;11(2):185–95.PubMedPubMedCentral Klein H, Washington TA. The pre-exposure prophylaxis (PrEP) stigma scale: preliminary findings from a pilot study. Int Public Health J. 2019;11(2):185–95.PubMedPubMedCentral
98.
go back to reference Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J et al. Validation of the HIV Pre-Exposure Prophylaxis Stigma Scale: performance of likert and semantic differential scale versions. AIDS Behav. 2020;24(9):2637-49. Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J et al. Validation of the HIV Pre-Exposure Prophylaxis Stigma Scale: performance of likert and semantic differential scale versions. AIDS Behav. 2020;24(9):2637-49.
99.
go back to reference Rogers EM. Diffusion of preventive innovations. Addict Behav. 2002;27(6):989–93.PubMed Rogers EM. Diffusion of preventive innovations. Addict Behav. 2002;27(6):989–93.PubMed
100.
go back to reference Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, et al. Contraception as a potential gateway to pre-exposure prophylaxis: US women’s pre-exposure prophylaxis modality preferences align with their birth control practices. AIDS Patient Care STDS. 2020;34(3):132–46. Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, et al. Contraception as a potential gateway to pre-exposure prophylaxis: US women’s pre-exposure prophylaxis modality preferences align with their birth control practices. AIDS Patient Care STDS. 2020;34(3):132–46.
Metadata
Title
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation
Author
Sarah K. Calabrese
Publication date
01-12-2020
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 6/2020
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-020-00533-y

Other articles of this Issue 6/2020

Current HIV/AIDS Reports 6/2020 Go to the issue

The Science of Prevention (JD Stekler and JM Baeten, Section Editors)

A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies

The Science of Prevention (JD Stekler and JM Baeten, Section Editors)

Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men

Co-infections and Comorbidity (S Naggie, Section Editor)

NASH in HIV

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.